The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 152.50
Bid: 150.00
Ask: 155.00
Change: -5.00 (-3.17%)
Spread: 5.00 (3.333%)
Open: 157.50
High: 157.50
Low: 152.50
Prev. Close: 157.50
ITX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

1 Jul 2022 14:37

RNS Number : 0753R
Itaconix PLC
01 July 2022
 

For immediate release

 

Itaconix plc

("Itaconix" or the "Company")

Result of Annual General Meeting

and

Board Change

Itaconix (AIM: ITX) (OTCQB: ITXXF), a leading innovator in plant-based specialty polymers used as essential ingredients in everyday consumer products, announces the results of the Annual General Meeting ("AGM") of its shareholders held at 1.00 pm today.

At the AGM, resolutions 1 to 3 (inclusive), 6 to 9 (inclusive), 11 and 12 were duly passed. Resolutions 4, 5 and 10 were not passed.

As a result, the Board now comprises Dr. James Barber (Non-Executive Chairman) and John R. Shaw (Chief Executive Officer).

John R. Shaw, Chief Executive Officer, commented: "We are active in the process of recruiting new members to our Board and will update the market in due course. I want to thank John Snow and Charlean Gmunder for their service to the Company."

In relation to those resolutions not passed, valid proxy instructions were as follows:

 

Ordinary resolutions

Votes For

Votes Against

Total Votes Cast

Votes Withheld

No of shares

% of shares voted

No of shares

% of shares voted

No of shares

% of ISC voted

No of shares

4. To re-appoint John I. Snow III as a Director of the Company

63,259,795

44.90%

77,626,866

55.10%

140,886,661

31.30%

316,420

5. To re-appoint Charlean Gmunder as a Director of the Company

66,848,169

47.45%

74,038,492

52.55%

140,886,661

31.30%

316,420

10. To approve and adopt the Itaconix plc 2022 Equity Participation Plan

25,133,646

20.84%

95,491,368

79.16%

120,625,014

26.80%

20,578,067

 

 

 

A copy of the resolutions are included in the Company's Circular and Notice of Annual General Meeting which is available on the Company's website: www.itaconix.com/investor/reports-documents/

 

- Ends -

 

For further information please contact:

Itaconix plc

+1 603 775 4400

John R. Shaw / Laura Denner

Belvedere Communications

+44 (0) 74 070 23147

John West / Llew Angus

finnCap

+44 (0) 20 7220 0500

Ed Frisby / Abigail Kelly / Milesh Hindocha (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

 

About Itaconix

Itaconix uses its proprietary plant-based polymer technology platform to produce and sell specialty ingredients that improve the safety, performance, and sustainability of consumer products. The Company's current ingredients are enabling and leading new generations of products in detergents, hygiene, and hair care. Itaconix's contributions to the global low carbon economy are recognised by the London Stock Exchange's Green Economy Mark.

www.itaconix.com

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGXFLFBLDLXBBE
Date   Source Headline
20th Nov 20137:00 amRNSMarketing approval of nicotine gum in Europe
17th Oct 20137:00 amRNSSupply and Distribution Agreement with Amma Polska
11th Oct 20137:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
25th Sep 20137:00 amRNSInterim Results
1st Aug 20137:00 amRNSTotal Voting Rights
22nd Jul 20137:00 amRNSAward of contract to supply nicotine gum
15th Jul 201312:20 pmRNSChange of Registered Office
9th Jul 20137:00 amRNSBlocklisting Interim Review
28th May 20132:02 pmRNSResult of AGM
17th Apr 20134:47 pmRNSHolding(s) in Company
17th Apr 20137:00 amRNSDirector's Dealings
9th Apr 20137:00 amRNSPositive test results for encapsulation technology
22nd Mar 20137:00 amRNSNotice of AGM and Posting of Annual Report
13th Mar 20137:00 amRNSPreliminary Results
1st Mar 20137:00 amRNSTotal Voting Rights
1st Feb 20132:42 pmRNSNotice of patent infringement proceedings
10th Jan 20137:01 amRNSAwards under Long Term Incentive Plan
10th Jan 20137:00 amRNSBlock Listing
8th Jan 20131:59 pmRNSHolding(s) in Company
19th Dec 20122:14 pmRNSEstablishment of Employee Benefit Trust
19th Dec 20127:00 amRNSTrading Update
25th Sep 20127:00 amRNSInterim Results
13th Sep 20127:00 amRNSBoard Appointment
17th Aug 20127:00 amRNSIssue of Warrants
30th Jul 20127:00 amRNSCanadian Distribution Deals Won
10th Jul 20128:09 amRNSBoard Appointment
10th Jul 20128:05 amRNSAIM Admission - First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.